Korro Bio, Inc. (KRRO)

Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $147.92 million. The enterprise value is $45.45 million.

Market Cap	147.92M
Enterprise Value	45.45M

Important Dates

The last earnings date was Tuesday, March 18, 2025, before market open.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Korro Bio has 9.39 million shares outstanding. The number of shares has increased by 483.30% in one year.

Current Share Class	9.39M
Shares Outstanding	9.39M
Shares Change (YoY)	+483.30%
Shares Change (QoQ)	+0.69%
Owned by Insiders (%)	6.41%
Owned by Institutions (%)	60.80%
Float	4.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	68.50
Forward PS	n/a
PB Ratio	1.02
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.28.

Current Ratio	8.79
Quick Ratio	8.54
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.61% and return on invested capital (ROIC) is -28.14%.

Return on Equity (ROE)	-50.61%
Return on Assets (ROA)	-25.65%
Return on Invested Capital (ROIC)	-28.14%
Return on Capital Employed (ROCE)	-43.50%
Revenue Per Employee	$21,837
Profits Per Employee	-$803,663
Employee Count	104
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, Korro Bio has paid $141,000 in taxes.

Income Tax	141,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.30%
50-Day Moving Average	28.25
200-Day Moving Average	41.11
Relative Strength Index (RSI)	30.50
Average Volume (20 Days)	93,215

Short Selling Information

The latest short interest is 826,301, so 8.80% of the outstanding shares have been sold short.

Short Interest	826,301
Short Previous Month	834,167
Short % of Shares Out	8.80%
Short % of Float	16.82%
Short Ratio (days to cover)	12.01

Income Statement

In the last 12 months, Korro Bio had revenue of $2.27 million and -$83.58 million in losses. Loss per share was -$9.37.

Revenue	2.27M
Gross Profit	2.27M
Operating Income	-91.91M
Pretax Income	-81.17M
Net Income	-83.58M
EBITDA	-88.35M
EBIT	-91.91M
Loss Per Share	-$9.37

Balance Sheet

The company has $126.10 million in cash and $44.77 million in debt, giving a net cash position of $118.29 million or $12.60 per share.

Cash & Cash Equivalents	126.10M
Total Debt	44.77M
Net Cash	118.29M
Net Cash Per Share	$12.60
Equity (Book Value)	160.42M
Book Value Per Share	17.11
Working Capital	116.57M

Cash Flow

In the last 12 months, operating cash flow was -$60.07 million and capital expenditures -$17.90 million, giving a free cash flow of -$77.98 million.

Operating Cash Flow	-60.07M
Capital Expenditures	-17.90M
Free Cash Flow	-77.98M
FCF Per Share	-$8.31

Margins

Gross Margin	100.00%
Operating Margin	-4,047.12%
Pretax Margin	-3,674.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-483.30%
Shareholder Yield	n/a
Earnings Yield	-51.04%
FCF Yield	-47.62%

Analyst Forecast

The average price target for Korro Bio is $132.17, which is 738.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$132.17
Price Target Difference	738.91%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	123.67%
EPS Growth Forecast (5Y)	7.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Korro Bio has an Altman Z-Score of 1.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.73
Piotroski F-Score	1